Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Glycosylphosphatidylinositol-anchor intermediates associate with Triton-insoluble membranes in subcellular compartments that include the endoplasmic reticulum
Sevlever, Daniel , PICKETT, Samuel, MANN, Karl J., Medof, M. Edward , Rosenberry, Terrone L. , Sambamurti, Kumar

Biochemical Journal | August 10, 2015 | Volume: 343 | Issue: 3 | Pages: 627-635

10.1042/bj3430627 Get It

Glycosylphosphatidylinositol (GPI)-anchored proteins are resistant to solubilization with Triton X-100 at 4 °C, and they can be recovered in Triton-insoluble membranes (TIMs) that float to a characteristic buoyant density. Because the GPI structure itself has been shown to target GPI-anchored proteins to TIMs, we investigated the association of GPI-anchor intermediates with TIMs. GPI-anchor biosynthesis involves a pathway of some 10 steps that take place in the endoplasmic reticulum (ER). These intermediates include glucosaminyl-acylphosphatidylinositol [GlcN-(acyl)PI] and later mannosylated GPIs, denoted H6, H7 and H8, that are present not only in the ER but also in other cell compartments, including the plasma membrane. At least two-thirds of the GlcN-(acyl)PI in HeLa D cells and mannosylated GPIs in K562 cells were found in TIMs. Although previous reports have considered TIMs to be derived primarily from the plasma membrane, we recovered TIMs from subcellular fractions enriched in ER membranes. The ER marker calnexin and GPI-anchored proteins as well as N-acetylglucosaminyl-phosphatidylinositol and mannosylated GPIs were present in ER-TIMs. Interestingly, GlcN-PI and H7 were less enriched in ER-TIM than the other GPIs, suggesting that ER-TIMs might reflect a compartmentalization of the GPI-anchor biosynthetic pathway in the ER.
The electrolyte distribution and the acid-base equilibrium in the serum in cases of nephritis and nephritic acidosis
Greene, Carl H., Wakefield, Elmer G., Power, Marschelle H., Keith, Norman M.

Biochemical Journal | August 10, 2015 | Volume: 26 | Issue: 5 | Pages: 1377-1382

10.1042/bj0261377 | PMID 16744955 Get It

Histidine-193 of rat glucosylceramide synthase resides in a UDP-glucose- and inhibitor (D-threo-1-phenyl-2-decanoylamino-3-morpholinopropan-1-ol)-binding region: a biochemical and mutational study
Wu, Kangjian, Marks, David L. , Watanabe, Rikio, Paul, Pascal, RAJAN, Niveda, Pagano, Richard E.

Biochemical Journal | August 10, 2015 | Volume: 341 | Issue: 2 | Pages: 395-400

10.1042/bj3410395 Get It

Glucosylceramide synthase (GCS) catalyses the transfer of glucose from UDP-glucose (UDP-Glc) to ceramide to form glucosylceramide, the common precursor of most higher-order glycosphingolipids. Inhibition of GCS activity has been proposed as a possible target of chemotherapeutic agents for a number of diseases, including cancer. Design of new GCS inhibitors with desirable pharmaceutical properties is hampered by lack of knowledge of the secondary structure or catalytic mechanism of the GCS protein. Thus we cloned the rat homologue of GCS to begin studies to identify its catalytic regions. The histidine-modifying agent diethyl pyrocarbonate (DEPC) inhibited recombinant rat GCS expressed in bacteria; this inhibition was rapidly reversible by hydroxylamine and could be diminished by preincubation of GCS with UDP-Glc. These data suggest that DEPC acts on histidine residues within or near the UDP-Glc-binding site of GCS. Mutant proteins were expressed in which the eight histidine residues in GCS were individually replaced by other amino acids. H193A (His193 → Ala) and H193N (His193 → Asn) mutants were unaffected by 0.1 mM DEPC, a concentration that inhibited other histidine mutants and the wild-type enzyme by at least 60%. These results indicate that His193 is the primary target of DEPC and is at, or near, the UDP-Glc-binding site of GCS. His193 mutants were also insensitive to the GCS inhibitor D - threo - 1 - phenyl - 2 - decanoylamino - 3 - morpholinopropan - 1 - ol, at concentrations which inhibited the wild-type enzyme by > 80%. These results have significance for both an understanding of the GCS active site and also for the possible design of new and specific inhibitors of GCS.
Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER‐I trial: Technical performance
Alli, Oluseun , Rihal, Charanjit S. , Suri, Rakesh M. , Greason, Kevin L. , Waksman, Ron , Minha, Sa’ar , Torguson, Rebecca, Pichard, Augusto D., Mack, Michael J. , Svensson, Lars G. , Rajeswaran, Jeevanantham , Lowry, Ashley M. , Ehrlinger, John, Tuzcu, E. Murat , Thourani, Vinod H. , Makkar, Raj , Leon, Martin B. , Holmes, David R. , Rihal, Charanjit S. , Blackstone, Eugene H.

Catheterization and Cardiovascular Interventions | August 10, 2015 | Volume: 87 | Issue: 1 | Pages: 154-162

10.1002/ccd.26120 | PMID 26256280 Get It

ObjectivesTo assess technical performance learning curves of teams performing transfemoral transcatheter aortic valve replacement (TF‐TAVR).BackgroundTF‐TAVR is a new procedure for treating severe aortic stenosis. The number of cases required for procedural efficiency is unknown.MethodsIn the PARTNER‐I trial, 1,521 patients underwent TF‐TAVR from 4/2007–2/2012. Learning curve analysis of technical performance metrics was performed using institution‐specific patient sequence number, interval between procedures, and institutional trial entry date. Learning curve characteristics were assessed using semi‐parametric and parametric mixed‐effects models.ResultsAs patient sequence number increased, average procedure time decreased from 154 to 85 minutes (P < 0.0001), and fluoroscopy time from 28 to 20 minutes (P < 0.0001). Procedure time plateaued at an average of 83 minutes (range 52–140). Procedure time plateau was dynamic during the course of the trial, averaging 25 cases (range 21–52) by its end. The later institutions enrolled in the trial, the shorter the initial procedure time. During the trial, percutaneous rather than surgical access increased from 7.9% to 69%.ConclusionsTechnical performance learning curves exist for TF‐TAVR; procedural efficiency increased with experience, with concomitant decreases in radiation and contrast media exposure. The number of cases needed to achieve efficiency decreased progressively, with optimal procedural performance reached after approximately 25 cases for late‐entering institutions. Knowledge and experience accumulated by early TF‐TAVR institutions were disseminated, shortening the learning curve of late‐entering institutions. Technological advances resulting from learning during the trial moved the field from initial conservative surgical cut‐down to percutaneous access for most patients. © 2015 Wiley Periodicals, Inc.
Management of Crohn's disease in pregnancy
Beery, Renée M. Marchioni, Kane, Sunanda V.

British Journal of Hospital Medicine | August 8, 2015 | Volume: 76 | Issue: 8 | Pages: 455-463

10.12968/hmed.2015.76.8.455 | PMID 26255915 Get It

Crohn's disease is a chronic inflammatory bowel disease commonly diagnosed during the reproductive years. Disease management involves advocating conception during periods of stable clinical remission and continuing safe medications throughout pregnancy to achieve optimal maternal and fetal outcomes.
Late‐onset recurrent mania as a manifestation of Wallenberg syndrome: a case report and review of the literature
Das, Piyush , Rai, Abhishek , Kuppuswamy, Preetha Sharone, Chopra, Amit

Bipolar Disorders | August 8, 2015 | Volume: 17 | Issue: 6 | Pages: 677-682

10.1111/bdi.12318 | PMID 26257194 Get It

ObjectiveThe aim of the present case report was to describe the late onset of recurrent mania in a patient after ischemic injury to the cerebellum and dorsolateral medulla.MethodsWe studied an 86‐year‐old male with no prior psychiatric history who developed recurrent episodes of mania following a brain stroke. Additionally, he had neurological symptom constellation typical of Wallenberg syndrome.ResultsMagnetic resonance imaging of the brain revealed infarction in the inferomedial right cerebellar hemisphere and the right dorsolateral medulla in the right posterior inferior cerebellar artery (PICA) distribution. He was successfully managed with a combination of antipsychotic and mood‐stabilizer medications.ConclusionsPost‐stroke mania may be one of the rare manifestations of Wallenberg syndrome. This case adds to the emerging literature on cerebellar involvement in mood regulation and pathology of mania.
Soluble guanylate cyclase modulators blunt hyperoxia effects on calcium responses of developing human airway smooth muscle
Britt, Rodney D. , Kuipers, Ine, Stewart, Alecia, Vogel, Elizabeth R. , Thu, James, Martin, Richard J. , Prakash, Y. S. , Thompson, Michael A. , Pabelick, Christina M. , Prakash, Y S , Vogel, Elizabeth R

American Journal of Physiology-Lung Cellular and Molecular Physiology | August 8, 2015 | Volume: 309 | Issue: 6 | Pages: L537-L542

10.1152/ajplung.00232.2015 | PMID 26254425 Get It

Exposure to moderate hyperoxia in prematurity contributes to subsequent airway dysfunction and increases the risk of developing recurrent wheeze and asthma. The nitric oxide (NO)-soluble guanylate cyclase (sGC)-cyclic GMP (cGMP) axis modulates airway tone by regulating airway smooth muscle (ASM) intracellular Ca2+([Ca2+]i) and contractility. However, the effects of hyperoxia on this axis in the context of Ca2+/contractility are not known. In developing human ASM, we explored the effects of novel drugs that activate sGC independent of NO on alleviating hyperoxia (50% oxygen)-induced enhancement of Ca2+responses to bronchoconstrictor agonists. Treatment with BAY 41–2272 (sGC stimulator) and BAY 60-2770 (sGC activator) increased cGMP levels during exposure to 50% O2. Although 50% O2did not alter sGCα1or sGCβ1expression, BAY 60-2770 did increase sGCβ1expression. BAY 41-2272 and BAY 60-2770 blunted Ca2+responses to histamine in cells exposed to 50% O2. The effects of BAY 41-2272 and BAY 60-2770 were reversed by protein kinase G inhibition. These novel data demonstrate that BAY 41-2272 and BAY 60-2770 stimulate production of cGMP and blunt hyperoxia-induced increases in Ca2+responses in developing ASM. Accordingly, sGC stimulators/activators may be a useful therapeutic strategy in improving bronchodilation in preterm infants.
Coming to terms with tissue engineering and regenerative medicine in the lung
Prakash, Y. S. , Tschumperlin, Daniel J. , Stenmark, Kurt R. , Prakash, Y S

American Journal of Physiology-Lung Cellular and Molecular Physiology | August 8, 2015 | Volume: 309 | Issue: 7 | Pages: L625-L638

10.1152/ajplung.00204.2015 | PMID 26254424 Get It

Lung diseases such as emphysema, interstitial fibrosis, and pulmonary vascular diseases cause significant morbidity and mortality, but despite substantial mechanistic understanding, clinical management options for them are limited, with lung transplantation being implemented at end stages. However, limited donor lung availability, graft rejection, and long-term problems after transplantation are major hurdles to lung transplantation being a panacea. Bioengineering the lung is an exciting and emerging solution that has the ultimate aim of generating lung tissues and organs for transplantation. In this article we capture and review the current state of the art in lung bioengineering, from the multimodal approaches, to creating anatomically appropriate lung scaffolds that can be recellularized to eventually yield functioning, transplant-ready lungs. Strategies for decellularizing mammalian lungs to create scaffolds with native extracellular matrix components vs. de novo generation of scaffolds using biocompatible materials are discussed. Strengths vs. limitations of recellularization using different cell types of various pluripotency such as embryonic, mesenchymal, and induced pluripotent stem cells are highlighted. Current hurdles to guide future research toward achieving the clinical goal of transplantation of a bioengineered lung are discussed.
Residents’ knowledge of quality improvement: the impact of using a group project curriculum
Duello, Katherine, Louh, Irene K., Greig, Hope E, Dawson, Nancy L. , Greig, Hope, Dawson, Nancy

Postgraduate Medical Journal | August 7, 2015 | Volume: 91 | Issue: 1078 | Pages: 431-435

10.1136/postgradmedj-2014-132886 | PMID 26253922 Get It

ABSTRACT Background The Accreditation Council for Graduate Medical Education requires residents to learn and demonstrate proficiency in practice improvement. Quality improvement (QI) projects are a way to improve patient care as well as facilitate education on this core competency. There are inherent barriers to completing these goals in the structure of residency training including rigorous resident schedules and a limited number of projects and resources. Objectives We developed a QI programme using an experiential class project and incorporated it into our Internal Medicine Resident Core Curriculum to improve the residents’ knowledge of QI methods. We assessed the residents’ experience, knowledge and interest in practice and QI subject matter with a survey preimplementation and postimplementation. Methods In 2009, 24 residents in the Internal Medicine resident programme completed a survey measuring their experience, knowledge and interest in QI initiatives. They then completed a QI 1-year programme, with monthly, 1-hour sessions combining didactics and a resident-designed project. At the conclusion of the year, the residents completed the same survey, and the results were compared and analysed. Results Postcurriculum questionnaires revealed residents were more knowledgeable about QI methods, showing improvement in knowledge about institutional-wide QI projects, better preparation for implementing a QI project, and more likely to participate in QI in the future. The project completed was one which improved patients’ knowledge of their anticipated date of discharge from the hospital. Conclusions A class quality project can teach QI to residents incorporating both didactic and practical methods to maximise the experience and minimise the barriers. We found that this method improved residents experience, knowledge and interest in quality initiatives.
T Cell Adolescence: Maturation Events Beyond Positive Selection
Xing, Yan , Hsu, Fan‐Chi , Shapiro, Virginia Smith , Hogquist, Kristin Ann

The Journal of Immunology | August 7, 2015 | Volume: 195 | Issue: 4 | Pages: 1351-1357

10.4049/jimmunol.1501050 | PMID 26254267 Get It

Abstract Single-positive thymocytes that successfully complete positive and negative selection must still undergo one final step, generally termed T cell maturation, before they gain functional competency and enter the long-lived T cell pool. Maturation initiates after positive selection in single-positive thymocytes and continues in the periphery in recent thymic emigrants, before these newly produced T cells gain functional competency and are ready to participate in the immune response as peripheral naive T cells. Recent work using genetically altered mice demonstrates that T cell maturation is not a single process, but a series of steps that occur independently and sequentially after positive selection. This review focuses on the changes that occur during T cell maturation, as well as the molecules and pathways that are critical at each step.